People with allergies may be more likely to have mental health disorders, study finds
People with asthma, atopic dermatitis and hay fever may be more likely to suffer from depression, anxiety, bipolar disorder and other mental health disorders, a study published by Clinical and Experimental Allergy found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 6, 2021 Category: Consumer Health News Source Type: news

Allergies including asthma and hay fever not linked to mental health traits
Allergic diseases such as asthma, atopic dermatitis and hay fever do not cause the onset of mental health conditions or vice versa, according to the findings of a new University of Bristol-led study published today (6 October) in the journal Clinical and Experimental Allergy. (Source: University of Bristol news)
Source: University of Bristol news - October 6, 2021 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Population Health Sciences, Faculty of Life Sciences, Faculty of Life Sciences, School of Psychological Science; Press Release Source Type: news

What Causes Facial Pain?
Discussion Dental caries are one of the most common infections. It is usually caused by Streptococcus viridans. Dental caries are also quite preventable with brushing the teeth at least twice a day with a fluoridated dentifrice, use of dental floss, and preventative dental appointments with application of fluoride varnish and sealants as appropriate. Fluoridated water supplies also help. A review can be found here. Facial pain is often acute, self-limited and etiologies that may be obvious such as trauma or infection. Facial pain can also overlap with cranial pain (mainly headache), neck pain (often lymphadenopathy or musc...
Source: PediatricEducation.org - October 4, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Management of Pediatric Food Allergies Evolving Management of Pediatric Food Allergies Evolving
New focus emphasizes exposure to allergens rather than of blanket avoidance, although this approach may not always work in atopic dermatitis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 28, 2021 Category: Consumer Health News Tags: Dermatology News Source Type: news

Lab notes: Incyte gets two FDA approvals, Coriell gets $12.4M research grant, and more
This week's roundup on the region's life sciences industry includes one company securing two FDA approvals, a South Jersey institution receiving a $12 million research grant, and more. Here's the rundown: Incyte Corp. The Wilmington biotechnology company started the week receiving marketing clearance from the Food and Drug Administration for Opzelura, the company's topical cream for mild-to-moderate atopic dermatitis — a chronic skin disease that affects more than 21 million people in the Unit ed… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2021 Category: Pharmaceuticals Authors: John George Source Type: news

FDA Approves First Topical JAK Inhibitor for Atopic Dermatitis FDA Approves First Topical JAK Inhibitor for Atopic Dermatitis
The approval is for the treatment of non-immunocompromised patients aged 12 years and older with mild to moderate atopic dermatitis.FDA Approvals (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 22, 2021 Category: Internal Medicine Tags: Dermatology News Alert Source Type: news

New Data on RYBREVANT ® (amivantamab-vmjw) in Combination with Lazertinib Show Early Activity in Patients with Non-Small Cell Lung Cancer Whose Disease Has Progressed After Both Osimertinib and Platinum-Based Chemotherapy
September 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced preliminary results from the Phase 1b CHRYSALIS-2 (NCT04077463) study evaluating RYBREVANT® (amivantamab-vmjw) in combination with lazertinib in the treatment of patients with non-small cell lung cancer (NSCLC) characterized by epidermal growth factor receptor (EGFR) exon 19 deletion or L858R mutations whose disease had progressed after treatment with osimertinib and platinum chemotherapy.[i] While previously reported results have demonstrated durable responses with RYBREVANT® in combination with...
Source: Johnson and Johnson - September 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

RYBREVANT ® (amivantamab-vmjw) Provides Higher Activity and Longer Duration of Response When Used in Combination with Lazertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer Who Have Failed Osimertinib
September 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced a new analysis from the CHRYSALIS (NCT02609776) study evaluating RYBREVANT® (amivantamab-vmjw) monotherapy and a combination regimen with lazertinib in advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations who progressed after osimertinib.[1] The analysis showed higher activity and longer duration of response (DOR) in patients treated with the combination therapy, demonstrating the potential benefit of targeting the extracellular (outer) and catal...
Source: Johnson and Johnson - September 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Association Between Atopic Dermatitis and Autoimmune Diseases Association Between Atopic Dermatitis and Autoimmune Diseases
This large population-based study explored the association between atopic dermatitis and a wide spectrum of autoimmune diseases. Which autoimmune disorders had the strongest association?The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 15, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress
September 8, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than ten data presentations from its lung cancer, bladder cancer and prostate cancer portfolio and pipeline will be featured during the European Society for Medical Oncology (ESMO) Annual Congress 2021 virtual meeting, September 16–21. Further details about these data and the science Janssen is advancing will be made available throughout ESMO via the Janssen Oncology Virtual Newsroom.“With a diverse oncology portfolio and pipeline spanning bladder cancer, lung cancer and prostate can...
Source: Johnson and Johnson - September 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Mayo Clinic Minute: Patch testing for allergic contact dermatitis
If you've ever experienced a red, itchy rash appear on your skin after using a certain lotion or even from wearing jewelry, you may be experiencing contact dermatitis. It's caused by a substance you're exposed to that irritates your skin. However, it also can be triggered by an allergic reaction.In this Mayo Clinic Minute, Dr. Matthew Hall, a Mayo Clinic dermatologist, explains how patch testing is crucial to assess for allergic contact dermatitis. Watch: The… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 3, 2021 Category: Databases & Libraries Source Type: news

Severe Eczema Tied to Depression, Internalizing Behaviors in Children
Mild - to - moderate atopic dermatitis not linked to symptoms of depression, but linked to internalizing behaviors from age 4 years (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 2, 2021 Category: Psychiatry Tags: Dermatology, Family Medicine, Pediatrics, Psychiatry, Allergy, Journal, Source Type: news

Severe Eczema Tied to Depression, Internalizing Behaviors in Children
WEDNESDAY, Sept. 1, 2021 -- Severe atopic dermatitis (AD) is associated with symptoms of depression and internalizing behaviors throughout childhood, according to a study published online Sept. 1 in JAMA Dermatology. Chloe Kern, from the University... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 1, 2021 Category: Pharmaceuticals Source Type: news

Atopic Dermatitis: A Personal Journey Atopic Dermatitis: A Personal Journey
Dr Stadtmauer, an allergist-immunologist, has lived with atopic dermatitis and eczema for nearly his entire life.Medscape Allergy & Immunology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology Viewpoint Source Type: news

Factors Linked to Development of Pediatric Psoriasis Identified
TUESDAY, Aug. 24, 2021 -- Atopic dermatitis, a family history of psoriasis, and skin viral and bacterial infection and fungal infections in early life are associated with pediatric psoriasis development, according to a study published in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 24, 2021 Category: Pharmaceuticals Source Type: news

European Commission Approves RINVOQ(R) (upadacitinib) as First JAK Inhibitor in the European Union for the Treatment of Both Adults and Adolescents with Moderate to Severe Atopic Dermatitis
Approval supported by data from one of the largest registrational Phase 3 programs in atopic dermatitis evaluating RINVOQ (upadacitinib) monotherapy or with topical corticosteroids[1] RINVOQ met all primary and secondary endpoints, demonstrating rapid a... Biopharmaceuticals, Dermatology, Regulatory AbbVie, RINVOQ, upadacitinib, atopic dermatitis, JAK inhibitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 24, 2021 Category: Pharmaceuticals Source Type: news

Eczema rash: Is that itchy patch indicative of a gluten sensitivity?
AN ECZEMA skin rash that is bumpy and itchy could be indicative of dermatitis herpetiformis - a common complaint for people with a gluten sensitivity. (Source: Daily Express - Health)
Source: Daily Express - Health - August 24, 2021 Category: Consumer Health News Source Type: news

Upadacitinib Effective and Safe in Atopic Dermatitis at 52 Weeks Upadacitinib Effective and Safe in Atopic Dermatitis at 52 Weeks
The JAK inhibitor shows efficacy and safety when used in combination with topical corticosteroids, and showed superiority in a head-to-head comparison with dupilumab.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 19, 2021 Category: Dermatology Tags: Allergy & Clinical Immunology News Source Type: news

Janssen Presents Phase 1 Results for RYBREVANTTM (amivantamab-vmjw) in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations
August 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced preliminary data from the Phase 1 CHRYSALIS study evaluating RYBREVANTTM (amivantamab-vmjw) for the treatment of patients with non-small cell lung cancer (NSCLC) with mesenchymal-epithelial transition (MET) exon 14 skipping (METex14) mutations. The initial data showed anti-tumor activity in patients with METex14 mutations and a safety profile consistent with reported experience at the approved CHRYSALIS Phase 2 dose (RYBREVANTTM 1050 mg [
Source: Johnson and Johnson - August 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Lilly's lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic dermatitis in two Phase 3 trials
Primary and all key secondary endpoints including itch, interference of itch on sleep and quality of life were met at Week 16 in two pivotal Phase 3 trials in lebrikizumab clinical trial program Safety profile consistent with prior lebrikizumab studies ... Biopharmaceuticals, Dermatology Eli Lilly, lebrikizumab, atopic dermatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 16, 2021 Category: Pharmaceuticals Source Type: news

Eczema (Atopic Dermatitis) Quiz:
Title: Eczema (Atopic Dermatitis) Quiz:Category: MedicineNet QuizCreated: 3/20/2012 12:50:00 PMLast Editorial Review: 8/16/2021 5:55:36 PM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - August 16, 2021 Category: Dermatology Source Type: news

Androgenetic Alopecia Has an Adverse Effect on Quality of Life Androgenetic Alopecia Has an Adverse Effect on Quality of Life
Pooled quality of life scores for androgenetic alopecia were higher than scores for other skin conditions including alopecia areata, contact dermatitis, and acne vulgaris.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 10, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Atopic Dermatitis and Psychiatric Disorders in Childhood Atopic Dermatitis and Psychiatric Disorders in Childhood
Other than ADHD, which is known to be associated with atopic dermatitis in children, are there other psychiatric conditions or treatments associated with childhood AD?The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 5, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Atopic dermatitis and patient perspectives: insights of bullying at school and career discrimination at work - Stingeni L, Belloni Fortina A, Baiardini I, Hansel K, Moretti D, Cipriani F.
BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by recurrent eczematous lesions and intense pruritus. AD patients are known to face a considerable disease burden, including physical and emotional limitations. There i... (Source: SafetyLit)
Source: SafetyLit - July 31, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Five Do's and Five Don'ts for Managing Atopic Dermatitis Five Do's and Five Don'ts for Managing Atopic Dermatitis
Many common treatments for atopic dermatitis are based on little clinical evidence, researchers say in a new review.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 28, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

Five Do's and Five Don'ts for Managing Dermatitis
Five Do's and Five Don'ts for Managing Atopic Dermatitis (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 28, 2021 Category: General Medicine Source Type: news

How Do You Treat Immersion Foot Injury?
Discussion All occupations have some type of potential health consequences. Some are obvious because of the environment such as kitchen workers, first responders, helicopter pilots, etc. Others are may be less obvious or not considered such as slip and falls, cleaning supply chemical exposure, animal bites for postal and utility workers, etc. Noise and lifting objects are often overlooked problems in some settings but obvious in others such as construction. Protective measures, especially appropriate education and training and protective clothing and safety gear are obviously important for performing the work as safely as ...
Source: PediatricEducation.org - July 26, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Face Mask-Related Injuries Rose Dramatically in 2020 Face Mask-Related Injuries Rose Dramatically in 2020
Dermatitis was the most common mask-related injury treated last year.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 23, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Proposed Classification Framework for Atopic Dermatitis Unveiled Proposed Classification Framework for Atopic Dermatitis Unveiled
Goals include standardizing the assessment of AD in clinical practice and making it easier to tailor therapy to individual patient characteristics.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 16, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Incidence of occupational contact dermatitis in healthcare workers: a systematic review
Healthcare workers (HCWs) can be considered at an increased risk of developing occupational contact dermatitis (OCD) due to repetitive hand washing with soaps and disinfectants and extended use of gloves for many hours during the day. The aim of this study was to summarize the incidence of OCD in HCWs. We searched the databases PubMed/MEDLINE (1980-present), EMBASE (1980-present) and Cochrane Library (1992-present) through May 2020 using the search term'incidence of contact dermatitis in HCWs'according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Overall, 16 studies (six cohort...
Source: Current Awareness Service for Health (CASH) - July 16, 2021 Category: Consumer Health News Source Type: news

Questionnaire Responses About Dermatology History Inconsistent
TUESDAY, July 13, 2021 -- Asking people about a history of psoriasis may be useful for assessing psoriasis prevalence, but a similar questionnaire assessing atopic dermatitis does not appear to be as reliable of a method, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2021 Category: Pharmaceuticals Source Type: news

DR ELLIE CANNON: Will I have itchy red spots on my feet for the rest of my life?
DR ELLIE CANNON: In most cases like this, it is a flare-up of a skin condition called dermatitis, although another cause of an irritating rash can be an inflammatory condition (file photo pictured). (Source: the Mail online | Health)
Source: the Mail online | Health - July 3, 2021 Category: Consumer Health News Source Type: news

Survey Spotlights the Out-of-Pocket Burden on Blacks With Atopic Dermatitis Survey Spotlights the Out-of-Pocket Burden on Blacks With Atopic Dermatitis
The clinical phenotype and burden of AD can vary across racial and ethnic groups, according to the investigator.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 28, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

What Triggers Seborrheic Dermatitis Symptoms
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 18, 2021 Category: General Medicine Source Type: news

Hand Hygiene Habits and Prevalence of Hand Eczema During the COVID-19 Pandemic
Conclusion: In terms of hand eczema prevention, we suggest that the use of alcohol-based products should be discontinued if other handwashing methods are available. The following factors increase the risk of hand eczema: being a HCW, having previous hand eczema, and having underlying atopic dermatitis. Proper strategies in terms of hand eczema prevention should be addressed, especially in this group, since we need to continue performing hand hygiene during the ongoing COVID-19 pandemic. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 17, 2021 Category: Consumer Health News Source Type: news

Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis
WILMINGTON, Del.--(BUSINESS WIRE) June 11, 2021 -- Incyte Corporation (Nasdaq:INCY) announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for ruxolitinib cream for the... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - June 11, 2021 Category: Drugs & Pharmacology Source Type: news

What Are Some Indications for Using Dexamethasone?
Discussion Corticosteroids are a group of drugs which can be naturally or synthetically produced. Naturally occurring substances are produced in the adrenal gland, and are protein-bound (primarily corticosteroid-binding globulin and albumin). In the target tissues, they may need to be converted to an active substance. They are then reduced, oxidized, hydroxylated or conjugated as measures to inactivate them. Synthetic steroids have less protein binding and depending on their structure are more or less resistant to inactivation. Prednisone is the glucocorticoid most often used for treatment, especially as it has a short hal...
Source: PediatricEducation.org - June 7, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs
June 1, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 30 company-sponsored studies, including six oral presentations, will be featured during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8. Janssen presentations will include new data and updates for both approved and investigational therapeutics that are being studied for the treatment of various solid tumors and blood cancers. Immediately following ASCO, additional data will be featured during the European Hematology Association (EHA) Virtual Congress, June 9-17. A ...
Source: Johnson and Johnson - June 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis
Agreement Renews Successful Global Collaboration That led to Several Groundbreaking Therapies in Multiple Disease Areas KHK4083 Depletes OX40-Expressing T cells Associated with Atopic Dermatitis and Several Other Inflammatory Diseases Moderate-to-Sev... Biopharmaceuticals, Dermatology Amgen, Kyowa Kirin, atopic dermatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 1, 2021 Category: Pharmaceuticals Source Type: news

Rare Intervention for Incontinence-Associated Dermatitis Rare Intervention for Incontinence-Associated Dermatitis
In this article, two rare cases of incontinence-associated dermatitis that presented as chemical burns are discussed. How were these patients managed?Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 28, 2021 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news

RYBREVANTTM (amivantamab-vmjw) Receives FDA Approval as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
May 21, 2021 (HORSHAM, P.A.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has granted the accelerated approval of RYBREVANTTM (amivantamab-vmjw) for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy.[1] RYBREVANTTM is the first fully-human, bispecific antibody approved for the treatment of patients with NSCLC t...
Source: Johnson and Johnson - May 21, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Upadacitinib Treats Moderate-to-Severe Atopic Dermatitis
FRIDAY, May 21, 2021 -- Upadacitinib shows short-term efficacy for moderate-to-severe atopic dermatitis in adolescents and adults, according to a study published online May 20 in The Lancet. Emma Guttman-Yassky, M.D., from the Icahn School of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 21, 2021 Category: Pharmaceuticals Source Type: news

Pivotal results from Trinity clinical trial for the chronic condition atopic dermatitis
(Trinity College Dublin) Trinity College Dublin and St James's Hospital, Dublin clinical trials reported efficacy and safety results of upadacitinib compared with placebo for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents. This pivotal Global Phase 3 study involved 1,600 patients and took place over a two-year period. Results show the drug to so far be the most effective treatment for atopic dermatitis in clinical trials. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 21, 2021 Category: International Medicine & Public Health Source Type: news

Updated Amivantamab and Lazertinib Combination Data Demonstrate Durable Responses and Clinical Activity for Osimertinib-Relapsed Patients with EGFR-Mutated Non-Small Cell Lung Cancer
May 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated data from the Phase 1 CHRYSALIS study showing treatment with amivantamab in combination with lazertinib led to a median duration of response (DOR) of 9.6 months in chemotherapy-naïve patients with non-small cell lung cancer (NSCLC) and epidermal growth factor receptor (EGFR) exon 19 deletion or L858R mutations whose disease had progressed after treatment with osimertinib.[1] These data, which will be presented in an oral presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual ...
Source: Johnson and Johnson - May 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Internet-Delivered CBT Reduces Atopic Dermatitis Symptoms
WEDNESDAY, May 19, 2021 -- Internet-delivered cognitive behavior therapy (CBT) reduces symptoms of atopic dermatitis, according to a study published online May 19 in JAMA Dermatology. Erik Hedman-Lagerlöf, Ph.D., from the Karolinska Institutet... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 19, 2021 Category: Pharmaceuticals Source Type: news

Photoprotection Recommended for People of Color Photoprotection Recommended for People of Color
Photoprotection for people of color helps minimize the development of photodermatoses, postinflammatory hyperpigmentation, polymorphous light eruption, and chronic actinic dermatitis.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 17, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Spontaneous Resolution of Atopic Dermatitis With Benralizumab Spontaneous Resolution of Atopic Dermatitis With Benralizumab
This patient experienced spontaneous resolution of atopic dermatitis while participating in a trial of benralizumab for severe asthma, highlighting the potential shared mechanisms of these conditions.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 13, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Baricitinib Shows Long-Term Efficacy for Atopic Dermatitis
THURSDAY, May 13, 2021 – Baricitinib demonstrates sustained long-term efficacy in patients with moderate-to-severe atopic dermatitis, according to a study published online May 12 in JAMA Dermatology. Jonathan I. Silverberg, M.D., from the George... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 13, 2021 Category: Pharmaceuticals Source Type: news

Hand Dermatitis Currently Prevalent in Health Care Workers
Prevalence of hand dermatitis 92.6 percent in health care workers, 68.7 percent for general population (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - May 12, 2021 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Hand Dermatitis Currently Prevalent in Health Care Workers
WEDNESDAY, May 12, 2021 -- More than 90 percent of health care workers and two-thirds of the general population currently have hand dermatitis, according to a study presented at the European Academy of Dermatology and Venereology Spring Symposium,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 12, 2021 Category: Pharmaceuticals Source Type: news